Latest PCT Stories
Results of Studies by Three Key Opinion Leader Laboratories Demonstrate Significant Advantages in Drug Discovery, Cancer Detection, and in the Analysis of Microorganism Diversity in Soil SOUTH
Powertech Offers Strong Distribution and Support Network of 20 Offices/Laboratories, Over 60 Sales/Marketing/Service/Engineering Staff, and Multiple Sub-dealers Throughout China SOUTH
The Company Expects to Build and Ship Nine Instrument Systems for Evaluation between Mid-October and Late November.
ALLENDALE, N.J., July 18, 2011 /PRNewswire/ -- Progenitor Cell Therapy (PCT), an internationally recognized cell therapy services and development company, and a wholly-owned subsidiary of NeoStem, Inc. (NYSE Amex: NBS), an international biopharmaceutical company with operations in the U.S.
SOUTH EASTON, Mass., Dec. 1 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc.